BioAtla (BCAB) Assets Average (2021 - 2025)

BioAtla's Assets Average history runs 5 years deep, the most recent figure standing at $10.1 million for Q4 2025.

• On a quarterly basis, Assets Average fell 82.39% year-over-year to $10.1 million in Q4 2025; TTM through Dec 2025 was $10.1 million, a 82.39% decrease from a year earlier, with the FY2025 full-year figure at $28.4 million, down 67.05% from the prior year.
• Assets Average eased to $10.1 million in Q4 2025 per BCAB's latest filing, from $21.5 million in the prior quarter.
• Across five years, Assets Average topped out at $266.0 million in Q4 2021 and bottomed at $10.1 million in Q4 2025.
• The 5-year median for Assets Average is $178.8 million (2023), against an average of $148.5 million.
• Across the five-year window, Assets Average increased 2.33% in 2022 and slumped 82.39% in 2025, its largest moves.
• Year by year, Assets Average stood at $266.0 million in 2021, then retreated by 22.02% to $207.4 million in 2022, then plunged by 34.67% to $135.5 million in 2023, then plunged by 57.69% to $57.3 million in 2024, then slumped by 82.39% to $10.1 million in 2025.
• Per Business Quant, the three latest BCAB Assets Average figures stand at $10.1 million (Q4 2025), $21.5 million (Q3 2025), and $32.7 million (Q2 2025).